Skip to main content

93 7325 (Trandolapril 1 mg)

Pill with imprint 93 7325 is Beige, Capsule-shape and has been identified as Trandolapril 1 mg. It is supplied by Teva Pharmaceuticals USA.

Trandolapril is used in the treatment of left ventricular dysfunction; high blood pressure; diabetic kidney disease; heart attack; heart failure and belongs to the drug class Angiotensin Converting Enzyme Inhibitors. There is positive evidence of human fetal risk during pregnancy. Trandolapril 1 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 93 7325

Trandolapril 1 mg 93 7325
Trandolapril 1 mg 93 7325
Trandolapril 1 mg 93 7325 Front
Trandolapril 1 mg 93 7325 Back
Trandolapril 1 mg 93 7325
Trandolapril 1 mg 93 7325


93 7325
1 mg
8.00 mm
Prescription only
Drug Class
Angiotensin Converting Enzyme Inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Teva Pharmaceuticals USA
Inactive Ingredients
ferric oxide yellow, lactose anhydrous, povidone k30, corn starch, sodium stearyl fumarate, FD&C Blue No. 2, indigotindisulfonate sodium, aluminum oxide, FD&C Red No. 40, FD&C Yellow No. 6

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00093-7325 (Discontinued) Teva Pharmaceuticals USA, Inc.
42291-0837 AvKare, Inc.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.